Gazeta Wrocławska: Bioceltix develops biological drugs for common pet diseases. At the moment, the company is working on drugs for locomotor system diseases (osteoarthritis), autoimmune diseases (atopic dermatitis) and various types of cancer.
– The products that we create use the analgesic and anti-inflammatory properties of mesenchymal stem cells, which makes them a modern alternative to symptomatic treatment with the use of steroidal and non-steroidal anti-inflammatory drugs – said Łukasz Bzdzion.
Read more here.